EW
40
-4
ETR
52
3
NUE
43
3
DAL
53
-2
SHW
61
2
AVGO
40
3
DNB
44
6
ZTS
58
-2
EMC
93
4
GE
65
-2
XEL
50
-3
FSLR
47
-11
MMM
30
-3
MPC
47
3
PNC
48
6
STX
57
-3
FLR
35
-5
R
63
2
APD
32
-5
ABBV
68
2
EW
40
-4
ETR
52
3
NUE
43
3
DAL
53
-2
SHW
61
2
AVGO
40
3
DNB
44
6
ZTS
58
-2
EMC
93
4
GE
65
-2
XEL
50
-3
FSLR
47
-11
MMM
30
-3
MPC
47
3
PNC
48
6
STX
57
-3
FLR
35
-5
R
63
2
APD
32
-5
ABBV
68
2
Financhill
Back

American Financial Group Vs. Keros Therapeutics Industry Stock Comparison

Sell
33

AFG
American Financial Group

Last Price:
122.97
Seasonality Move:
0.1%
Sell
27

KROS
Keros Therapeutics

Last Price:
45.71
Seasonality Move:
4.22%
Sell
33
American Financial Group (AFG) is a Sell

Is American Financial Group a Buy, Sell or Hold?

  • The current American Financial Group [AFG] share price is $123.02. The Score for AFG is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • AFG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AFG Stock Price Chart

What is American Financial Group's stock price today?

  • The American Financial Group share price today is $123.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AFG is experiencing slight selling pressure.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

AFG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.17 Sell
Relative Strength Index (14 RSI): 37.35 Sell
Chaikin Money Flow: -293694 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.85 - 128.35) Sell
Bollinger Bands (100): (124.83 - 131.89) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 38.41 Sell
Chaikin Money Flow: 239305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.72 - 49.1) Sell
Bollinger Bands (100): (49.87 - 64.91) Sell

AFG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.55 Sell
20-day SMA: 126.39 Sell
50-day SMA: 128.21 Sell
200-day SMA: 121.35 Buy
8-day EMA: 125.02 Sell
20-day EMA: 126.2 Sell
50-day EMA: 127.46 Sell
200-day EMA: 124.45 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.61 Buy
20-day SMA: 47.29 Sell
50-day SMA: 51.65 Sell
200-day SMA: 47.07 Sell
8-day EMA: 45.93 Sell
20-day EMA: 47.34 Sell
50-day EMA: 50.89 Sell
200-day EMA: 50 Sell

American Financial Group Earnings Growth & AFG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.11 per share, an increase this year of $0.35 per share, and an increase next year of $0.88 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

American Financial Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):